These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Gene therapy for hemophilia: a review on clinical benefit, limitations, and remaining issues. Leebeek FWG; Miesbach W Blood; 2021 Sep; 138(11):923-931. PubMed ID: 34232980 [TBL] [Abstract][Full Text] [Related]
5. AAV-mediated gene transfer for hemophilia. High KA Ann N Y Acad Sci; 2001 Dec; 953():64-74. PubMed ID: 11795424 [TBL] [Abstract][Full Text] [Related]
6. Current and future prospects for hemophilia gene therapy. Ward P; Walsh CE Expert Rev Hematol; 2016 Jul; 9(7):649-59. PubMed ID: 27153210 [TBL] [Abstract][Full Text] [Related]
7. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia. High KA Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929 [TBL] [Abstract][Full Text] [Related]
8. [Development of gene therapy for hemophilia: current states and future perspectives]. Ohmori T Rinsho Ketsueki; 2018; 59(10):2238-2246. PubMed ID: 30305531 [TBL] [Abstract][Full Text] [Related]
9. Hemophilia gene therapy: ushering in a new treatment paradigm? George LA Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):226-233. PubMed ID: 34889378 [TBL] [Abstract][Full Text] [Related]
10. Advances in gene therapy for hemophilia: basis, current status, and future perspectives. Ohmori T Int J Hematol; 2020 Jan; 111(1):31-41. PubMed ID: 30083852 [TBL] [Abstract][Full Text] [Related]
11. The gene therapy journey for hemophilia: are we there yet? High KA Hematology Am Soc Hematol Educ Program; 2012; 2012():375-81. PubMed ID: 23233607 [TBL] [Abstract][Full Text] [Related]
12. Advances and challenges for hemophilia gene therapy. Batty P; Lillicrap D Hum Mol Genet; 2019 Oct; 28(R1):R95-R101. PubMed ID: 31332444 [TBL] [Abstract][Full Text] [Related]
14. The gene therapy journey for hemophilia: are we there yet? High KA Blood; 2012 Nov; 120(23):4482-7. PubMed ID: 22829631 [TBL] [Abstract][Full Text] [Related]
15. New and improved AAVenues: current status of hemophilia B gene therapy. Brimble MA; Reiss UM; Nathwani AC; Davidoff AM Expert Opin Biol Ther; 2016; 16(1):79-92. PubMed ID: 26524468 [TBL] [Abstract][Full Text] [Related]
16. Current status of haemophilia gene therapy. High KH; Nathwani A; Spencer T; Lillicrap D Haemophilia; 2014 May; 20 Suppl 4():43-9. PubMed ID: 24762274 [TBL] [Abstract][Full Text] [Related]
17. Gene therapy for hemophilia: past, present and future. George LA; Fogarty PF Semin Hematol; 2016 Jan; 53(1):46-54. PubMed ID: 26805907 [TBL] [Abstract][Full Text] [Related]
18. AAV vectors for hemophilia B gene therapy. Chao H; Walsh CE Mt Sinai J Med; 2004 Oct; 71(5):305-13. PubMed ID: 15543431 [TBL] [Abstract][Full Text] [Related]
19. Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects. Baruteau J; Waddington SN; Alexander IE; Gissen P J Inherit Metab Dis; 2017 Jul; 40(4):497-517. PubMed ID: 28567541 [TBL] [Abstract][Full Text] [Related]
20. Practical Implications of Factor IX Gene Transfer for Individuals with Hemophilia B: A Clinical Perspective. Miesbach W; Sawyer EK Hum Gene Ther Clin Dev; 2018 Jun; 29(2):80-89. PubMed ID: 29624465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]